Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (15): 2305-2309.doi: 10.3969/j.issn.2095-4344.2015.15.002

Previous Articles     Next Articles

Pyrroloquinoline quinone promotes chondrocyte proliferation and inhibits interleukin-1beta-induced chondrocyte apoptosis

Zhang Zhen-jiang, Lv Guo-feng   

  1. Department of Sports Medicine, Dalian Medical University, Dalian 116044, Liaoning Province, China
  • Revised:2015-03-18 Online:2015-04-09 Published:2015-04-09
  • Contact: Lv Guo-feng, Master’s supervisor, Department of Sports Medicine, Dalian Medical University, Dalian 116044, Liaoning Province, China
  • About author:Zhang Zhen-jiang, Studying for master’s degree, Department of Sports Medicine, Dalian Medical University, Dalian 116044, Liaoning Province, China

Abstract:

BACKGROUND: Pyrroloquinoline quinone is found to accelerate Schwann cell proliferation and growth factor secretion, but there is no report addressing its role in articular cartilage and chondrocytes. 
OBJECTIVE: To investigate the role of pyrroloquinoline quinone in chondrocyte proliferation and interleukin-1β-induced chondrocyte apoptosis in the articular cartilage of knee joints and to verify the protective mechanism involved.
METHODS: Chondrocytes were isolated from New Zealand white rabbits (1 month of age), digested under aseptic conditions, and cultured in DMEM/F12 in the presence of 10% fetal bovine serum to allow for proliferation until passage 2. Adherent chondrocytes were cultured in serum-free DMEM/F12 medium with 0, 6.25, 12.5, 25.0, 50.0 and 100.0 μmol/L pyrroloquinoline quinone, separately. Proliferation activity was determined by MTT at 48 hours of pyrroloquinoline quinone administration. Cell cycle was determined by flow cytometry at 30 hours after pyrroloquinoline quinone administration. Apoptosis was determined by flow cytometry following 24 hours of pyrroloquinoline quinone pretreatment and 15 hours of interleukin-1β induction.
RESULTS AND CONCLUSION: Pyrroloquinoline quinone enhanced chondrocyte proliferation activity, increased percentage of S phase and G2/M phase in a dose dependent manner and reached the peak when the concentration of pyrroloquinoline quinone was 12.5-25.0 μmol/L (P < 0.05). Pyrroloquinoline quinone also inhibited interleukin-1β-induced chondrocyte apoptosis in early and late stage, and 25.0 μmol/L pyrroloquinoline quinone had the best effects (P < 0.05). These findings suggest pyrroloquinoline quinone can promote chondrocyte division and proliferation, and protect the cells from interleukin-1β-induced apoptosis.



中国组织工程研究
杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松组织工程


全文链接:

Key words: Chondrocytes, Interleukin-1beta, Apoptosis

CLC Number: